LONDON, UK, 15 March 2007 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) notes that its partner for zileuton CR, Critical Therapeutics (CTI), announced that it has entered into a co-promotion agreement with DEY, L.P., an affiliate of Merck KGaA.
LONDON, UK, 15 March 2007 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) notes that its partner for zileuton CR, Critical Therapeutics (CTI), announced that it has entered into a co-promotion agreement with DEY, L.P., an affiliate of Merck KGaA.
